Ebenbuild is a health tech pioneer that creates personalized treatment recommendations for mechanical ventilation and ICU patient care for clinical users. Founded in Munich in 2019, the company develops software tools that generate precise patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. These enable pinpoint individual medical decisions for intensive care patients with acute respiratory distress syndrome (ARDS). In this way, Ebenbuild aims to make a significant contribution to improving treatment as well as reducing mortality.
Improving ARDS treatment with digital twins: Ebenbuild secures seed financing round led by Bayern Kapital and High-Tech Gründerfonds